S&P 500   4,320.06
DOW   33,963.84
QQQ   357.91
High-speed rail was touted as a game-changer in Britain. Costs are making the government think twice
The single greatest medical breakthrough of all time? (Ad)
After climate summit, California Gov. Gavin Newsom faces key decisions to reduce emissions back home
Writers Guild and Hollywood studios reach tentative deal to end strike. No deal yet for actors
66,000% upside on tiny biotech? (Ad)
The threat of wildfires is rising. So are new artificial intelligence solutions to fight them
Canadian autoworkers ratify new labor agreement with Ford
66,000% upside on tiny biotech? (Ad)
Giorgio Armani closes Milan Fashion Week with good vibes and familiar guests in the front row
Hollywood's writers strike is on the verge of ending. What happens next?
S&P 500   4,320.06
DOW   33,963.84
QQQ   357.91
High-speed rail was touted as a game-changer in Britain. Costs are making the government think twice
The single greatest medical breakthrough of all time? (Ad)
After climate summit, California Gov. Gavin Newsom faces key decisions to reduce emissions back home
Writers Guild and Hollywood studios reach tentative deal to end strike. No deal yet for actors
66,000% upside on tiny biotech? (Ad)
The threat of wildfires is rising. So are new artificial intelligence solutions to fight them
Canadian autoworkers ratify new labor agreement with Ford
66,000% upside on tiny biotech? (Ad)
Giorgio Armani closes Milan Fashion Week with good vibes and familiar guests in the front row
Hollywood's writers strike is on the verge of ending. What happens next?
S&P 500   4,320.06
DOW   33,963.84
QQQ   357.91
High-speed rail was touted as a game-changer in Britain. Costs are making the government think twice
The single greatest medical breakthrough of all time? (Ad)
After climate summit, California Gov. Gavin Newsom faces key decisions to reduce emissions back home
Writers Guild and Hollywood studios reach tentative deal to end strike. No deal yet for actors
66,000% upside on tiny biotech? (Ad)
The threat of wildfires is rising. So are new artificial intelligence solutions to fight them
Canadian autoworkers ratify new labor agreement with Ford
66,000% upside on tiny biotech? (Ad)
Giorgio Armani closes Milan Fashion Week with good vibes and familiar guests in the front row
Hollywood's writers strike is on the verge of ending. What happens next?
S&P 500   4,320.06
DOW   33,963.84
QQQ   357.91
High-speed rail was touted as a game-changer in Britain. Costs are making the government think twice
The single greatest medical breakthrough of all time? (Ad)
After climate summit, California Gov. Gavin Newsom faces key decisions to reduce emissions back home
Writers Guild and Hollywood studios reach tentative deal to end strike. No deal yet for actors
66,000% upside on tiny biotech? (Ad)
The threat of wildfires is rising. So are new artificial intelligence solutions to fight them
Canadian autoworkers ratify new labor agreement with Ford
66,000% upside on tiny biotech? (Ad)
Giorgio Armani closes Milan Fashion Week with good vibes and familiar guests in the front row
Hollywood's writers strike is on the verge of ending. What happens next?
NYSE:CO

Global Cord Blood (CO) Stock Forecast, Price & News

$1.23
0.00 (0.00%)
(As of 09/22/2023 ET)
Compare
Today's Range
$1.23
▼
$1.23
50-Day Range
$0.90
▼
$1.84
52-Week Range
$2.03
▼
$5.50
Volume
118 shs
Average Volume
216,519 shs
Market Capitalization
$149.51 million
P/E Ratio
1.92
Dividend Yield
N/A
Price Target
N/A
ProfileChartCompetitorsFinancialsInstitutional OwnershipHeadlinesOptions ChainSEC FilingsShort InterestSocial Media

CO stock logo

About Global Cord Blood (NYSE:CO) Stock

Global Cord Blood operates as a holding company, which engages in the provision of cord blood banking services. It provides cord blood processing and storage service. The company also offers cord blood collection, laboratory testing, hematopoietic stem cell processing and stem cell storage services. The firm preserves cord blood units donated by the public and provides matching services on such donated units and deliver matching units to patients in need of transplants. Global Cord Blood was founded on January 17, 2008 and is headquartered in Hong Kong.

CO Price History

CO Stock News Headlines

September 19, 2023 | markets.businessinsider.com
ONWARD® Reports 2023 Half Year Results and Business Update
September 18, 2023 | msn.com
Spinal fluid test may enable earlier diagnosis of Parkinson's disease
September 24, 2023 | Legacy Research (Ad)
WARNING: Mandatory U.S. Dollar Recall is Weeks Away
If you have any U.S. dollars in your bank account… You must see this shocking video exposing the government’s new plan to recall the U.S. dollar. According to Business Insider, this recall “could be imminent.” And if you don’t prepare now, you could end up holding a bunch of worthless U.S. dollars.
September 17, 2023 | americanbankingnews.com
StockNews.com Begins Coverage on Global Cord Blood (NYSE:CO)
September 15, 2023 | benzinga.com
Cord Blood Banking Services Market Size is projected to reach USD 5.37 Billion by 2031, growing at a CAGR of 13.8%: Straits Research
August 29, 2023 | businesswire.com
Global Blood & Plasma Components Market Outlook 2023-2027 with Revenue Shares by Product, Application, End-user and Company - ResearchAndMarkets.com
August 28, 2023 | businesswire.com
Global Cord Blood & Tissue Banking Industry Report 2023: Cord Blood Market Dominated by Top 12 Banking Operators, Accounting for Over 70% Control - ResearchAndMarkets.com
August 24, 2023 | finance.yahoo.com
Global Cord Blood & Tissue Banking Industry Report 2023 - Industry Witnesses Robust Consolidation as Investor Demand Surges
September 24, 2023 | Chaikin Analytics (Ad)
His system isolated NVIDIA - Here's His Next Buy.
Most investors don't know the truth about A.I. 50-year Wall Street Insider Marc Chaikin reveals what you should be doing to profit. Learn more here.
August 16, 2023 | finance.yahoo.com
GLOBAL NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET FORECAST 2023-2032
August 1, 2023 | finance.yahoo.com
Global Stem Cell Banking Market to Reach $14.3 Billion by 2030: Adult Stem Cell Research Gains Traction, Accelerating Research Funding
July 28, 2023 | benzinga.com
Chrissy Teigen Selects Cord Blood Registry® to Preserve Fourth Child's Newborn Stem Cells
July 27, 2023 | benzinga.com
National Marrow Donor Program® (NMDP)/Be The Match® Names Christina Melief, Ph.D., Senior Scientific Advisor
July 25, 2023 | finance.yahoo.com
Hematopoietic Stem Cell Transplantation Global Market Report 2023
July 10, 2023 | finance.yahoo.com
Be The Match BioTherapies® Marks Cord Blood Awareness Month with the Announcement of the Cord Blood Bank Alliance
July 10, 2023 | benzinga.com
Blood Market to grow by USD 2,195.69 million from 2022-2027|Rising number of hospitals and blood banks to boost the market- Technavio
June 21, 2023 | morningstar.com
Global Cord Blood Corp Shs Stock Settlement
June 16, 2023 | msn.com
Disused Avon Campus In Rye To Get New Life Through NY Blood Center
June 9, 2023 | uk.finance.yahoo.com
Global Cell Isolation/Cell Separation Market Report 2023: Growing Focus on Personalized Medicine Fuels the Sector
June 9, 2023 | finance.yahoo.com
Bone Marrow Transplantation Global Market Report 2023
June 7, 2023 | markets.businessinsider.com
MAK-System partners with New York Blood Centre Enterprises
June 7, 2023 | technews.tmcnet.com
NYSE to Commence Delisting Proceedings Against Global Cord Blood Corporation (CO)
June 5, 2023 | benzinga.com
Blood Thawing System Market Poised to Reach USD 400 Mn by 2030, Driven by 7.3% CAGR: TMR Study
June 1, 2023 | msn.com
Companies Knew the Dangers of PFAS 'Forever Chemicals'—and Kept Them Secret
June 1, 2023 | finance.yahoo.com
Cell Therapy Global Market to Grow Rapidly at a CAGR of ~14% by 2028 | DelveInsight
May 31, 2023 | finance.yahoo.com
Global Biobanking Market Report 2023: Focus on Genetic Testing and Precision Medicine Drives Growth
May 31, 2023 | finance.yahoo.com
Global Allogeneic Cell Therapy Market to 2030: Increasing FDA Approvals of Allogeneic Cell Therapies Drives Growth
See More Headlines
Receive CO Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Global Cord Blood and its competitors with MarketBeat's FREE daily newsletter.

CO Company Calendar

Last Earnings
6/26/2018
Today
9/24/2023
Fiscal Year End
3/31/2024
Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange
NYSE
Industry
Miscellaneous health & allied services, not elsewhere classified
Sub-Industry
N/A
Sector
Medical
Current Symbol
NYSE:CO
CUSIP
N/A
CIK
1467808
Web
www.globalcordbloodcorp.com
Phone
(523) 605-8180
Fax
852-3605-8181
Employees
1,202
Year Founded
N/A

Profitability

EPS (Most Recent Fiscal Year)
N/A
Trailing P/E Ratio
1.92
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
N/A
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
N/A

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
N/A
Quick Ratio
N/A

Sales & Book Value

Annual Sales
$1.24 billion
Price / Sales
0.12
Cash Flow
$0.29 per share
Price / Cash Flow
4.19
Book Value
$6.34 per share
Price / Book
0.19

Miscellaneous

Outstanding Shares
121,551,000
Free Float
N/A
Market Cap
$149.51 million
Optionable
Optionable
Beta
0.16
The Best High-Yield Dividend Stocks for 2023 Cover
The Best High-Yield Dividend Stocks for 2023

Looking to generate income with your stock portfolio? Use these ten stocks to generate a safe and reliable source of investment income.

Get This Free Report

Key Executives

  • Ting Zheng
    Chairman & Chief Executive Officer
  • Bing Chuen Chen
    Chief Financial Officer & Director
  • Xin Xu
    Chief Technology Officer
  • Rui Arashiyama
    CEO-Guangdong & Zhejiang Divisions

Key Competitors

View All Competitors













CO Stock - Frequently Asked Questions

How have CO shares performed in 2023?

Global Cord Blood's stock was trading at $2.9876 on January 1st, 2023. Since then, CO stock has decreased by 58.8% and is now trading at $1.23.
View the best growth stocks for 2023 here.

How were Global Cord Blood's earnings last quarter?

Global Cord Blood Co. (NYSE:CO) released its quarterly earnings results on Tuesday, June, 26th. The medical research company reported $0.04 earnings per share for the quarter, missing analysts' consensus estimates of $0.13 by $0.09. The medical research company had revenue of $37.14 million for the quarter.

Is Global Cord Blood a good dividend stock?

Global Cord Blood (NYSE:CO) pays an annual dividend of $0.08 per share and currently has a dividend yield of 0.00%. The dividend payout ratio is 12.50%. This payout ratio is at a healthy, sustainable level, below 75%.
Read our dividend analysis for CO.

What other stocks do shareholders of Global Cord Blood own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Global Cord Blood investors own include AbbVie (ABBV), Fate Therapeutics (FATE), Gilead Sciences (GILD), Rigel Pharmaceuticals (RIGL), Spero Therapeutics (SPRO), Vertex Pharmaceuticals (VRTX), Enphase Energy (ENPH), Galectin Therapeutics (GALT), Intel (INTC) and Marvell Technology (MRVL).

What is Global Cord Blood's stock symbol?

Global Cord Blood trades on the New York Stock Exchange (NYSE) under the ticker symbol "CO."

How do I buy shares of Global Cord Blood?

Shares of CO stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Global Cord Blood's stock price today?

One share of CO stock can currently be purchased for approximately $1.23.

How much money does Global Cord Blood make?

Global Cord Blood (NYSE:CO) has a market capitalization of $149.51 million and generates $1.24 billion in revenue each year. The medical research company earns $79.04 million in net income (profit) each year or $0.64 on an earnings per share basis.

How many employees does Global Cord Blood have?

The company employs 1,202 workers across the globe.

How can I contact Global Cord Blood?

Global Cord Blood's mailing address is 48 FL. BANK OF CHINA TOWER 1 GARDEN ROAD, HONG KONG K3, . The official website for the company is www.globalcordbloodcorp.com. The medical research company can be reached via phone at (523) 605-8180, via email at ir@globalcordbloodcorp.com, or via fax at 852-3605-8181.

This page (NYSE:CO) was last updated on 9/24/2023 by MarketBeat.com Staff

My Account -